ZIM LABORATORIES Q2 FY27 ; NET LOSS AT ₹2 CR VS ₹0 CR (YOY), LOSS NARROWS 49% (QOQ)

REVENUE UP 19% AT ₹105 CR (YOY), UP 12% (QOQ) EBITDA DOWN 6% AT ₹5 CR (YOY), UP 121% (QOQ) MARGINS AT 5.1% VS 6.5% (YOY), 2.6% (QOQ)

ZIM LABORATORIES LIMITED